Although over 90 independent risk variants have been identified for Parkinson’s disease
using genome-wide association studies, most studies have been performed in just one …

Genome-wide association studies (GWAS) of Alzheimer’s disease are predominantly carried
out in European ancestry individuals despite the known variation in genetic architecture …

Parkinson’s disease has a large heritable component and genome-wide association studies
have identified over 90 variants with disease-associated common variants, providing …

Alzheimer’s Disease (AD) is a neurodegenerative disorder that is still not fully understood.
Sex modifies AD vulnerability, but the reasons for this are largely unknown. We utilize two …

Alzheimer’s disease (AD) is a pervasive neurodegenerative disorder that disproportionately
affects women. Since neural anatomy and disease pathophysiology differ by sex, …

METHODS: We examined single-cell RNA-sequencing (scRNA-seq) data from peripheral
blood mononuclear cells (PBMCs) and droplet digital (dd) PCR data from CD4 T cells from …

Background Emerging evidence from mouse models is beginning to elucidate the brain’s
immune response to tau pathology, but little is known about the nature of this response in …

Protein secondary structures are frequently assessed using infrared and circular dichroism
spectroscopies during drug development (eg, during product comparability and biosimilarity …

Alzheimer’s Disease (AD) is a complex neurodegenerative disease that gravely affects patients
and imposes an immense burden on caregivers. Apolipoprotein E4 (APOE4) has been …

The relationship between sleep disorders and neurodegeneration is complex and multi-faceted.
Using over one million electronic health records (EHRs) from Wales, UK, and Finland, …